期刊文献+

MACC1和c-Met在肾盂癌中的表达及其临床意义

Expressions of MACC1 and c-Met in renal pelvic carcinoma and its clinical significance
下载PDF
导出
摘要 目的:探讨结肠癌转移相关基因1(MACC1)及肝细胞生长因子受体(c-Met)在肾盂癌中的表达及其与肾盂癌发生、发展、浸润转移的关系。方法:采用免疫组织化学染色法检测73例肾盂癌组织及20例癌旁正常组织中MACC1和c-Met的表达情况,并结合临床病理因素进行相关分析。结果:在肾盂癌组织中MACC1和c-Met的高表达率均明显高于正常肾盂黏膜组织(P<0.05)。MACC1和c-Met的高表达与患者性别、年龄、病理分级、吸烟和尿脱落细胞学检查结果无关,而与病理分期相关(P<0.05)。肾盂癌中MACC1的高表达与c-Met的高表达呈正相关(r=0.450,P<0.01)。结论:MACC1和c-Met的异常高表达可能与肾盂癌的发生、发展及浸润转移密切相关,联合检测可作为判断肾盂癌生物学行为的重要指标。 Objective: To investigate the expressions of metastasis-associated in colon cancer 1 (MACC1) and hepatocyte growth factor receptor (c-Met) in renal pelvic carcinoma, and to demonstrate their relationship with the occurrence, development and metastasis of renal pelvic carcinoma. Methods: The expressions of MACC1 and c-Met in 20 cases of normal mucosa and 73 cases of renal pelvic carcinoma were detected by immnnohistochemistry, based on which the clinical pathological features were analyzed. Results: The high expressions of MACC1 and c-Met were significantly higher in renal pelvic carcinoma than that in normal mucosa of renal pelvis (P〈0.05). The high expressions of MACC 1 and c-Met were significantly related to differential pathological stage (P〈0.05), but not with sex, age, pathological degree, smoking and urine eytology (P〉0.05). A positive correlation was found between the high expressions of MACC1 and c-Met in renal pelvic carcinoma (r=0.450, P〈0.01). Conclusion: The high-expression of MACC 1 and c-Met may play an important role in the development, progression and metastasis of renal pelvic carcinoma. The combined detection of MACC 1 and c-Met can be used to determine the biological behavior and prognosis of renal pelvic carcinoma.
出处 《天津医科大学学报》 2013年第4期290-293,共4页 Journal of Tianjin Medical University
基金 天津市科委抗癌重大专项课题基金资助(12ZCDZSY16600)
关键词 结肠癌转移相关基因1 肝细胞生长因子受体 肾盂癌 免疫组织化学染色 MACC 1 c-Met renal pelvic carcinoma immunohistochemistry
  • 相关文献

参考文献14

  • 1Hall M C,Womack S, Sagalowsky A I,et al. Prognostic factors, re- currence and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients[J]. Urology, 1998,52(4):594. 被引量:1
  • 2Stein U,Walther W,Arlt F,et al. MACC1 ,a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis [J]. Nat Med,2009,15(1): 59. 被引量:1
  • 3Shirahata A,Fan W,Sakuraba K,et al. MACC1 as a marker for vascular invasive hepatocellular carcinoma[J]. Anticancer Res, 2011,31(3): 777. 被引量:1
  • 4van der Voort R,Taher T E,Derksen P W,et al. The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B- cell differentiation [J]. Adv Cancer Res, 2000,79:39. 被引量:1
  • 5Birchmeier C,Birchmeier W,Gherardi E,et al. Met,metastasis, motility and more [J]. Nat Rev Mol Cell Biol, 2003,4(12): 915. 被引量:1
  • 6Arh F,Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers[J]. Int J Biochem Cell Biol, 2009,41 (12): 2356. 被引量:1
  • 7Diep C B, Parada L A,Teixeira M R, et al. Genetic profiling of eol- orectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis[J]. Genes Chromosomes Cancer, 2003,36(2): 189. 被引量:1
  • 8Liotta L A, Stetler-Stevenson W G. Tumor invasion and metastasis: an imbalance of positive and negative regulation[J]. Cancer Res, 1991,51(18 Suppl):5054. 被引量:1
  • 9Steeg P S. Tumor metastasis: mechanistic insights and clinical chal- lenges [J]. Nat Med, 2006,12(8):895. 被引量:1
  • 10Munoz J J,Ellison L M. Upper tract urothelial neoplasms: inci- dence and survival during the last 2 decades[J]. Urology, 2000, 164(5): 1523. 被引量:1

二级参考文献12

  • 1Iborra I, Solsona E, Casanova J, et al. Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression. J Urol, 2003, 169:82- 85. 被引量:1
  • 2Brown GA, Busby JE, Wood CG, et al. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int, 2006, 98 : 1176-1180. 被引量:1
  • 3Keeley FX Jr, Bibbo M, Bagley DH. Ureteroscopic treat ment and surveillance of upper urinary tract transitional cell carcinoma. J Urol, 1997, 157:1560-1565. 被引量:1
  • 4Hall MC, Womack S, Sagalowsky AI, et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology, 1998, 52:594-601. 被引量:1
  • 5Munoz JJ, Ellison LM. Upper tract urothelial neoplasms:incidence and survival during the last 2 decades. J Urol, 2000, 164:1523 -1525. 被引量:1
  • 6Mohammadzadeh Rezaee M. Endoscopic resection of lower ureter in upper urinary tract tumors. Urol J, 2004, 1:208 -210. 被引量:1
  • 7Chen GL, Bagley DH. Ureteroscopic management of apper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol, 2000, 164 : 1173-1176. 被引量:1
  • 8Hisataki T, Miyao N, Masumori N, et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology, 2000, 55 : 663- 667. 被引量:1
  • 9Hafner C, Knueehel R, Stoehr R, et al. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic stu- dies. Int J Cancer, 2002, 101:1- 6. 被引量:1
  • 10Takahashi T, Habuchi T, Kakehi Y, et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res, 1998, 58:5835- 5841. 被引量:1

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部